Halozyme Therapeutics, Inc. HALO

$128.11 -2.14% at last close

Dividend

Halozyme Therapeutics, Inc. (HALO) does not currently pay a regular dividend, based on the most recent data available. Companies that retain earnings instead of paying dividends often reinvest in growth; check the financials page for how Halozyme Therapeutics, Inc. deploys its earnings.

Key Stats

Last Close
$128.11
Market Cap
$14.86 billion
52-Week Range
$61.23 – $134.00
Average Volume
2.32 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.